These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 17934917

  • 1. Risk factor control in treated hypertensives from Estonia and Sweden. Why the difference?
    Nilsson PM, Journath G, Palm K, Viigimaa M.
    Blood Press; 2007; 16(5):301-4. PubMed ID: 17934917
    [Abstract] [Full Text] [Related]

  • 2. Sex differences in risk factor control of treated hypertensives: a national primary healthcare-based study in Sweden.
    Journath G, Hellénius ML, Petersson U, Theobald H, Nilsson PM, Hyper-Q Study Group Sweden.
    Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):258-62. PubMed ID: 18525379
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hypertensive smokers have a worse cardiovascular risk profile than non-smokers in spite of treatment--a national study in Sweden.
    Journath G, Nilsson PM, Petersson U, Paradis BA, Theobald H, Erhardt L.
    Blood Press; 2005 Jun; 14(3):144-50. PubMed ID: 16036494
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up.
    Almgren T, Wilhelmsen L, Samuelsson O, Himmelmann A, Rosengren A, Andersson OK.
    J Hypertens; 2007 Jun; 25(6):1311-7. PubMed ID: 17563546
    [Abstract] [Full Text] [Related]

  • 9. [Influence of cardiovascular risk factors on prescribing of antihypertensives].
    Vaur L, Amar J, Perret M, Bailleau C, Etienne S, Chamontin B.
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):846-50. PubMed ID: 11575216
    [Abstract] [Full Text] [Related]

  • 10. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.
    Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Wahlberg E.
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):39-46. PubMed ID: 19237996
    [Abstract] [Full Text] [Related]

  • 11. Blood pressure control in Italy: results of recent surveys on hypertension.
    Volpe M, Tocci G, Trimarco B, Rosei EA, Borghi C, Ambrosioni E, Menotti A, Zanchetti A, Mancia G.
    J Hypertens; 2007 Jul; 25(7):1491-8. PubMed ID: 17563573
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A, Paolini I, Innocenti F, Mazzaglia G, Battaggia A, Brignoli O.
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.